Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?Somatuline depot patent expiry date?Antiox mebendazole price?Allergan's patent for latisse expired?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
See the DrugPatentWatch profile for Incruse
“Incruse” is the brand name for the COPD medicine umeclidinium.
Yes. Any generic product sold for “Incruse” uses the same active ingredient name: umeclidinium (it may be listed as umeclidinium bromide on labels).
Umeclidinium is used to help manage chronic obstructive pulmonary disease (COPD), typically to reduce symptoms by acting as a long-acting bronchodilator.
If you share the full label name (including strength, e.g., “62.5 mcg,” and whether it’s an inhalation powder), I can tell you the exact generic naming format used on that product.
Other Questions About Incruse :